NANOSONICS LIMITED — Director's Dealing 2019

Feb 25, 2019

==> picture [186 x 67] intentionally omitted <==

26 February 2019

Company Announcements Office Australian Securities Exchange

Appendix 3Y Change of Director’s Interest Notice

Attached is an Appendix 3Y - Change of Director’s Interest Notice in respect of changes in the relevant interests in securities held by Mr Michael Kavanagh, Chief Executive Officer and President.

On 26 February 2019 Mr Kavanagh sold a total of 310,000 Ordinary Shares. The sale of shares by Mr Kavanagh was required to fund a tax liability arising from the vesting and automatic exercise in 2017 of Performance Rights that were granted in 2013 as part of the 2013 Long Term Incentive Scheme and Performance Rights granted as part of the 2016 Short Term Incentive Scheme.

Following this sale, Mr Kavanagh continues to hold 1,018,363 shares. In addition, Mr Kavanagh holds 167,287 Performance Rights and 838,615 Options, which are subject to various vesting conditions.

McGregor Grant Secretary

About Nanosonics

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets. Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. For more information about Nanosonics please visit www.nanosonics.com.au

Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove NSW 2066 Australia Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: info@nanosonics.com.au w: www.nanosonics.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity		Nanosonics Limited
ABN	11	095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Mr Michael Kavanagh
Date of last notice	7 February 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	a) Indirect Interest b) Indirect Interest c) Indirect Interest d) Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	a) Performance Rights held in the Nanosonics Employee Share Option Plan. b) Performance Rights held in the Nanosonics Omnibus Equity Plan c) Options held in the Nanosonics Omnibus Equity Plan
Date of change	26 February 2019
No. of securities held prior to change	a) 206,882 Performance Rights held in the Nanosonics Employee Share Option Plan. b) 167,287 Performance Rights held in the Nanosonics Omnibus Equity Plan. c) 838,615 Options held in the Nanosonics Omnibus Equity Plan d) 1,328,363 (Direct) Ordinary Shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	a) Performance Rights b) Performance Rights c) Options d) Ordinary Shares
Number acquired	Nil
Number disposed	310,000 Ordinary Shares
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$1,293,375.49
No. of securities held after change	e) 206,882 Performance Rights held in the Nanosonics Employee Share Option Plan. f) 167,287 Performance Rights held in the Nanosonics Omnibus Equity Plan. g) 838,615 Options held in the Nanosonics Omnibus Equity Plan h) 1,018,363 (Direct) Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On-market sale of Ordinary Shares.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Mr. Michael Kavanagh Date: 26 February 2019

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3